Systems and methods for optimizing insulin dosage

Abstract

Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage, in particular a basal rate testing method, comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when one or more biomarker sampling parameters fall within a target biomarker range.

Description

[0001] Cross References to Related Applications [0002] This application is a continuation-in-part of U.S. Patent Application Serial No. 12 / 643,338 (WP 25378 US1), filed December 21, 2009, which claims priority to U.S. Provisional Application Serial No. 61 / 140,270, filed December 23, 2008 , both applications are hereby incorporated by reference in their entirety. technical field [0003] Embodiments of the present disclosure relate generally to diabetes management, and in particular to methods and systems for diabetics to optimize the doses of insulin they take. Background technique [0004] Illnesses of prolonged duration or frequent reoccurrence are usually defined as chronic diseases. Known chronic diseases include, inter alia, depression, obsessive-compulsive disorder, alcoholism, asthma, autoimmune diseases (eg ulcerative colitis, lupus), osteoporosis, cancer, and diabetes. Such chronic diseases require long-term care management for effective long-term treatment. Af...

AI Technical Summary

Problems solved by technology

The problem may include the following: the patient takes only the amount on the label attached to the package as originally prescribed by the physician; the patient eats before their blood glucose is sampled such that the sampling instance is unusable or inappropriate; Sampling; patients refusing to take more than the minimum amount because of fear; and not understanding instructions from physicians

Images